Back to Journals » Drug Design, Development and Therapy » Volume 13

Subcutaneous bortezomib might be standard of care for patients with multiple myeloma: a systematic review and meta-analysis

Total article views   HTML views PDF downloads Totals
6,659 Dovepress* 5,993+ 1,155 7,148
PubMed Central* 666 235 901
Totals 6,659 1,390 8,049
*Since 16 May 2019

View citations on PubMed Central and Google Scholar